<?xml version="1.0" encoding="UTF-8"?>
<p> As early as in 1978, it was shown that the complement system is necessary to protect mice from a lethal influenza infection [
 <xref rid="R44" ref-type="bibr">44</xref>]. In 1983, it was established that human serum contains antibodies capable of neutralizing the influenza virus by activating the classical complement pathway [
 <xref rid="R45" ref-type="bibr">45</xref>]. To date it is known that influenza virions can activate both the classical and alternative complement pathways, and that antibody opsonization is required for efficient lysis of virions [
 <xref rid="R46" ref-type="bibr">46</xref>]. 
</p>
